Nakhasi H L, Lynch K R, Dolan K P, Unterman R D, Feigelson P
Proc Natl Acad Sci U S A. 1981 Feb;78(2):834-7. doi: 10.1073/pnas.78.2.834.
When liver cells undergo malignant transformation, certain genes cease being expressed. We have studied the structure of one such gene, whose protein product we have designated hepatic protein 22 (hp22), which is not expressed in the two Morris hepatomas studied. We have prepared a chimeric clone of pBR322 containing cDNA sequences complementary to mRNA coding for this protein. By using this cloned cDNA, we have examined changes in expression of this gene and changes in the restriction pattern of the DNA isolated from normal liver and these hepatomas. In both hepatomas, studies using the isoschizomeric pair of restriction enzymes Msp I and Hpa II have indicated hypermethylation of a cytosine residue within or proximal to the hp22 gene. Other differences in the restriction pattern between normal liver and hepatoma DNA were also detected with EcoRI and Ava I. Thus, in the nontranscribed form of this gene, the DNA has undergone covalent modification, distinguishing these two hepatomas from each other and from normal liver.
当肝细胞发生恶性转化时,某些基因会停止表达。我们研究了其中一个这样的基因的结构,我们将其蛋白质产物命名为肝蛋白22(hp22),在所研究的两种莫里斯肝癌中该基因不表达。我们制备了一个pBR322的嵌合克隆,其中包含与编码该蛋白质的mRNA互补的cDNA序列。通过使用这个克隆的cDNA,我们检测了该基因表达的变化以及从正常肝脏和这些肝癌中分离的DNA的限制性酶切图谱的变化。在这两种肝癌中,使用同裂酶对Msp I和Hpa II进行的研究表明,hp22基因内部或其附近的一个胞嘧啶残基发生了高度甲基化。用EcoRI和Ava I也检测到了正常肝脏和肝癌DNA限制性酶切图谱的其他差异。因此,在该基因的非转录形式中,DNA发生了共价修饰,从而将这两种肝癌彼此区分开来,并与正常肝脏区分开来。